Using a closure analysis method to reduce CGT contamination risks
Many cell therapy manufacturing processes use open unit manipulations. As a result, they are at risk of potential contam...
BioPhorumConnect||Collaborate||Accelerate
Connect
||Collaborate
||Accelerate
Since its inception in 2004, BioPhorum has become the open and trusted environment where senior leaders of the biopharmaceutical industry come together to openly share and discuss the emerging trends and challenges facing their industry.
Growing from an end-user group in 2008, BioPhorum now comprises over 120 manufacturers and suppliers deploying their top 5000 leaders and subject matter experts to work in eight focused Phorums, articulating the industry’s technology roadmap, defining the supply partner practices of the future, and developing and adopting best practices in drug substance, fill finish, process development and manufacturing IT.
Newsletter subscribe
Enter your E-mail address to receive our monthly newsletter direct to your inbox.
You can unsubscribe at any time to clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.
Recent releases
Jan
09
2022
Addressing the challenges of using RNA as a therapeutic or a gene-editing tool
RNA technologies, including mRNA therapeutics, have emerged as a promising drug modality due to their essential biological role in protein expression and their...
Jan
09
2022
Supporting particle investigations with risk-based decision-making
BioPhorum’s Visual Inspection workstream has invested considerable time and effort to add clarity to the uncertainty around how to assess the risk of atypical particles...
Jan
09
2022
Using a closure analysis method to reduce CGT contamination risks
Many cell therapy manufacturing processes use open unit manipulations. As a result, they are at risk of potential contamination that can result in manufacturing batch...
Jan
09
2022
Bridging the worlds of IT and CGT through analogies
Cell and gene therapies (CGTs) have enormous potential to create personalized therapeutics for patients with diseases that were once untreatable – but they come with...
Nov
30
2021
How to replenish working cell banks with a risk-based scientific approach
Cell banks represent the fundamental starting substrates for biological drug substance/drug substance intermediate manufacturing. So, the availability of...
Nov
30
2021
How to make in-use stability and compatibility studies a success
In-use stability and compatibility studies are often used in biotherapeutic development to assess biologic drugs with diluents and/or administration components. The...
A powerful vehicle for change
BioPhorum facilitators bring leaders together to create future visions, mobilize teams of experts on the opportunities, create partnerships that enable change and provide the quickest route to implementation, so that the industry shares, learns and builds the best solutions together.
LONG READ
Chain reaction: how the biopharmaceutical supply chain survived the pandemic
Read more
Our mission
Bringing leaders together
to create future visions that focus the industry’s energy on the key emerging opportunities
Mobilizing communities
of the top experts around these opportunities, up and down the biopharma value chain
Creating partnerships
that enable change and provide the quickest route to implementation and results
Replacing isolation
with collaboration so that the industry shares, learns and
builds the best solutions together
Work with us
BioPhorum is a global collaboration of industry leaders and subject matter experts working together to pool knowledge, practices, and ideas, which lead to results that effect real change.